The Reliability of Activated Partial Thromboplastin Time Methods and the Relationship to Lipid Composition and Ultrastructure

Summary

Wide variations in procoagulant properties, lipid composition and ultrastructure of five commonly used APTT methods have been demonstrated. Performance of the methods with a range of coagulation abnormalities has been ranked. Most of the reagents obtained a high score with one or more defects, but a low score with others. A consistent good ranking throughout was only observed with one reagent.

The number of significant correlations between the reagents’ procoagulant activities and lipid content confirms the view that the performance of an APTT method is largely dependent upon its lipid composition. Marked differences in concentration and distribution of phospholipids, fatty acids and neutral lipids were evident. The importance of the concentration of phosphatidyl serine in regulating the procoagulant activity of an APTT method has been demonstrated. Electron microscopy provides evidence of the contrasting composition of the reagents from the more discrete uniform liposomes present in the more reliable reagents, to more ill-defined components present in those reagents which performed less well. The study highlights the need for standardisation of the APTT.

Key words

Activated partial thromboplastin time - Coagulation response - Lipid composition - Ultrastructure

• References

• 1 Poller L, Thomson JM, Palmer MK. The partial thromboplastin time: An international collaborative study. Lancet 1976; 2: 842-846
• 2 Poller L, Thomson JM, Yee KF. Heparin and partial thromboplastin time: an international survey. Br J Haematol 1980; 44: 161-165
• 3 Bligh EG, Dyer WJ. A rapid method of total lipid,extraction and purification. Can J Biochem Physiol 1959; 37: 911-917
• 4 Stevenson KJ, Easton AC, Thomson JM, Poller L. Lipid class composition and heparin sensitivity in the activated partial thromboplastin time. Thromb Haemostas 1983; 50: 601-603
• 5 Rouser G, Siakotos AN, Fleischer S. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1966; 1: 85-86
• 6 Stewart JC M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 1980; 104: 10-14
• 7 Metcalfe LD, Schmitz AA. The rapid preparation of fatty acid esters for gas chromatographic analysis. Anal Chem 1961; 33: 363-364
• 8 Box GE P, Cox DR. An analysis of transformations (with discussion). J R Stat Soc Series B 1964; 26: 211-252
• 9 Pearson ES, Hartley HO. Biometrika tables for statisticians Volume I. Biometrika Trust, London 1976; 146: 12
• 10 Siegel S. Nonparametric statistics for the behavioural sciences. McGraw Hill Book Company, Inc. Tokyo 1956; 202-213
• 11 Wetherill GB. Intermediate statistical methods. Chapman and Hall, London 1981; 13-16
• 12 Sibley CS, Singer JW, Wood RT. Comparison of activated partial thromboplastin reagents. Amer J Clin Pathol 1973; 59: 581-586
• 13 Hoffmann JJ M L, Meulendijk PN. Comparison of reagents for determining the activated partial thromboplastin time. Thromb Haemostas 1978; 39: 640-645
• 14 Hathaway WE, Assmus SL, Montgomery RR, Dubansky AS. Activated partial thromboplastin time and minor coagulopathies. Amer J Clin Pathol 1979; 71: 22-25
• 15 Mannucci PM. A multicenter evaluation of partial thromboplastin time reagents in the detection of mild haemophiliacs. In: Standardisation of coagulation assays: an overview. Triplett DA. (ed). CAP, Skokie,; Illinois: 1982: 165-177
• 16 Thomson JM, Poller L. The activated partial thromboplastin time. In: Blood coagulation and haemostasis - a practical guide, 3rd edition. Thomson JM. (ed). Churchill Livingstone; Edinburgh: 1985: 301-339
• 17 Brandt JT, Triplett DA. Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin . Amer J Clin Pathol 1981; 76: 530-537
• 18 Triplett DA, Harms CS, Koepke JA. The effect of heparin on the activated partial thromboplastin time. Amer J Clin Pathol 1978; 70: 556-559
• 19 Shapiro GA, Huntzinger SW, Wilson JeE. Variation among commercial activated partial thromboplastin time reagents in response to heparin. Amer J Clin Pathol 1977; 67: 477-480
• 20 Szoka F, Paphadjopoulos D. Liposomes: Preparation and characterization. In: Liposomes: From physical structure to therapeutic applications. Knight CG. (ed). Elsevier/North-Holland Biomedical Press; Amsterdam: 1981: 51-82
• 1 Chapman D. Physicochemical properties of phospholipids and lipid-water systems. In: Liposome Technology Volume I Preparation of liposomes. Gregoriadis G. (ed). CRC Press, Boca Raton; Florida: 1984: 1-18
• 22 Zwaal RF A. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta 1978; 515: 163-205
• 23 Stevenson KJ, Poller L. The procoagulant activity of partial thromboplastin extracts: the role of phosphatidyl serine. Thromb Res 1982; 26: 341-350
• 24 Barrowcliffe TW, Gray E. Studies of phospholipid reagents used in coagulation. I: Some general properties and their sensitivity to factor VIII. Thromb Haemostas 1981; 46: 629-633
• 25 Barrowcliffe TW, Gray E. Studies of phospholipid reagents used in coagulation. II: Factors influencing their sensitivity to heparin. Thromb Haemostas 1981; 46: 634-637
• 26 Slater PJ, Stevenson KJ, Poller L. Procoagulant activity of partial thromboplastin (cephalin) reagent and its phospholipid composition. Thromb Res 1980; 18: 831-842
• 27 Wagenvoord RJ, Zwaal RF A, Hemker HC. Entrapment of human factor VIII: C into liposomes prepared from bovine and horse erythrocyte membrane phospholipid. Thromb Haemostas 1983; 50: 117
• 28 Yashioka A, Peake IR, Furlong BL, Furlong RA, Giddings JC, Bloom AL. The interaction between factor VIII clotting antigen (VIIICAg) and phospholipid. Br J Haematol 1983; 55: 27-36
• 29 Bangham AD. A correlation between surface charge and coagulant action of phospholipids. Nature 1961; 192: 1197-1198
• 30 Papahadjopoulos D, Hougie C, Hanahan DJ. Influence of surface charge of phospholipids on their clot-promoting activity. Proc Soc exp Biol Med 1962; 111: 412-416
• 31 Kelsey PR, Stevenson KJ, Poller L. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time - The central role of phosphatidyl serine. Thromb Haemostas 1984; 52: 172-175
• 32 Mannucci PM, Canciani MT, Mari D, Meucci P. The varied sensitivity of partial thromboplastin time reagents in the demonstration of the lupus-like anticoagulant. Scand J Haematol 1979; 22: 423-432
• 33 Zwaal RF A, Comfurius P, van Deenen LL M. Membrane asymmetry and blood coagulation. Nature 1977; 268: 358-360